Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 14, 2026, 10:17 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1–24 of 151 matching trials from the live ClinicalTrials.gov search.

Filters: Sponsor: Endeavor Health Clear all

Conditions: Residual Neuromuscular Blockade
Interventions: Neostigmine, Sugammadex; Drug
Lead sponsor: Endeavor Health; Other
Eligibility: 18 Years to 80 Years
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2017
U.S. locations: 1
States / cities: Evanston, Illinois

Conditions: Pregnancy Related, Post Partum Hemorrhage
Interventions: Ultrasound; Other
Lead sponsor: Endeavor Health; Other
Eligibility: 17 Years and older · Female only
Enrollment: 1,725 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Evanston, Illinois

Conditions: Knee Osteoarthritis, Total Knee Arthroplasty (TKA)
Interventions: Pain Scale/Medication Log; Other
Lead sponsor: Endeavor Health; Other
Eligibility: 18 Years and older
Enrollment: 375 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2022
U.S. locations: 1
States / cities: Skokie, Illinois

Conditions: Pregnancy Complications
Interventions: Not listed
Lead sponsor: Endeavor Health; Other
Eligibility: 18 Years to 60 Years · Female only
Enrollment: 320 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Evanston, Illinois

Conditions: Asthma
Interventions: Electronic Medication Monitors on ICS and SABA - Active Mode, Electronic Medication Monitors on ICS and SABA - Silent Mode, Asthma App Tracking of ICS/SABA Usage - Active Mode, Asthma App Tracking of ICS/SABA Usage - Silent Mode, NorthShore Connect Real Time ICS and SABA Usage Feedback - Yes, NorthShore Connect Real Time ICS and SABA Usage Feedback - No, Asthma Nurse Monthly Phone Calls for ICS/SABA Usage Feedback - Yes, Asthma Nurse Monthly Phone Calls for ICS/SABA Usage Feedback - No; Behavioral
Lead sponsor: Endeavor Health; Other
Eligibility: 25 Years to 65 Years
Enrollment: 100 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Evanston, Illinois

Conditions: Small Fiber Neuropathy, Autoimmune Small Fiber Neuropathy, Inflammatory Polyneuropathy, Immune-Mediated Neuropathy
Interventions: Panzyga IVIG, Placebo; Drug
Lead sponsor: Endeavor Health; Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2028
U.S. locations: 1
States / cities: Glenview, Illinois

Conditions: Prostate Cancer
Interventions: Abiraterone acetate, Abiraterone acetate plus degarelix, Degarelix; Drug
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: 18 Years and older · Male only
Enrollment: 124 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2020
U.S. locations: 16
States / cities: Chicago, Illinois • Baltimore, Maryland • Detroit, Michigan + 12 more

Conditions: Wound Complication, Complications; Cesarean Section
Interventions: Tissue Adhesive, Sterile strips; Device
Lead sponsor: Endeavor Health; Other
Eligibility: Female only
Enrollment: 504 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2018
U.S. locations: 3
States / cities: Chicago, Illinois • Evanston, Illinois • Highland Park, Illinois

Conditions: Pelvic Pain
Interventions: Relugolix (40 mg) /estradiol (1 mg)/norethisterone acetate (0.5 mg) oral tablet; Drug
Lead sponsor: Endeavor Health; Other
Eligibility: 18 Years to 35 Years · Female only
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Evanston, Illinois

Conditions: Clostridium Difficile Infection
Interventions: Standard Practice to Prevent Hospital Onset CDI; Other
Lead sponsor: Endeavor Health; Other
Eligibility: Up to 1 Year
Enrollment: 148,549 participants
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: Evanston, Illinois

Conditions: Head and Neck Cancer
Interventions: Flexitouch Plus system; Device
Lead sponsor: Endeavor Health; Other
Eligibility: 18 Years to 100 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Respiratory Disease, Acute Respiratory Infection, Respiratory Infection, Upper Respiratory Infection
Interventions: Online Tutorial, Webinars, Booster Sessions, Feedback Reports, Parent Survey; Other
Lead sponsor: Seattle Children's Hospital; Other
Eligibility: 6 Months to 10 Years
Enrollment: 2,728 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2020
U.S. locations: 20
States / cities: Paragould, Arkansas • Eureka, California • Durango, Colorado + 16 more

Conditions: ICU Acquired Weakness
Interventions: TetraGraph, Electromyography, Nerve conduction studies; Device
Lead sponsor: Endeavor Health; Other
Eligibility: 18 Years to 90 Years
Enrollment: 24 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Evanston, Illinois

Conditions: Secondary Hyperparathyroidism, Chronic Kidney Disease
Interventions: Paricalcitol, Calcitriol; Drug
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 18 Years and older
Enrollment: 110 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2013
U.S. locations: 4
States / cities: Chicago, Illinois • Evanston, Illinois • Detroit, Michigan + 1 more

Conditions: Influenza Like Illness, Asthma, Group A Streptococcal Infection, Pertussis
Interventions: What's Going Around tool, Control; Other
Lead sponsor: Endeavor Health; Other
Eligibility: Not listed
Enrollment: 206,703 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2014
U.S. locations: 1
States / cities: Evanston, Illinois

Conditions: Ovarian Cancer, Chemotherapeutic Toxicity
Interventions: Fasting Mimicking Diet (Xentigen by L'Nutra), Carboplatin, Paclitaxel, Standard diet; Dietary Supplement · Drug
Lead sponsor: Endeavor Health; Other
Eligibility: 18 Years and older · Female only
Enrollment: 170 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2031
U.S. locations: 1
States / cities: Evanston, Illinois

Conditions: Postoperative Urinary Retention, Sacrospinous Vaginal Vault Suspension, Reconstructive Pelvic Surgery
Interventions: Tizanidine; Drug
Lead sponsor: Endeavor Health; Other
Eligibility: 18 Years to 99 Years · Female only
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Skokie, Illinois

Conditions: Dysmenorrhea, Pain
Interventions: Naproxen; Drug
Lead sponsor: Endeavor Health; Other
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 26 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2023
U.S. locations: 1
States / cities: Evanston, Illinois

Conditions: Microscopic Colitis
Interventions: Rifaximin 550mg; Drug
Lead sponsor: Eugene F Yen, MD; Other
Eligibility: 18 Years and older
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2021
U.S. locations: 1
States / cities: Evanston, Illinois

Conditions: Chronic Obstructive Pulmonary Disease
Interventions: Not listed
Lead sponsor: University of North Carolina, Chapel Hill; Other
Eligibility: 40 Years and older
Enrollment: 188 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2009
U.S. locations: 5
States / cities: Evanston, Illinois • Chapel Hill, North Carolina • Durham, North Carolina + 1 more

Conditions: Benign Prostatic Hyperplasia (BPH)
Interventions: Adalimumab; Drug
Lead sponsor: Endeavor Health; Other
Eligibility: 45 Years to 80 Years · Male only
Enrollment: 70 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2028
U.S. locations: 1
States / cities: Glenview, Illinois

Conditions: Total Shoulder Arthroplasty, Reverse Total Shoulder Arthroplasty
Interventions: Liposomal bupivacaine, Bupivacaine; Drug
Lead sponsor: Johnny K. Lee; Other
Eligibility: 18 Years to 90 Years
Enrollment: 78 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Skokie, Illinois

Conditions: Perinatal Depression
Interventions: Brief Behavioral Activation Treatment; Behavioral
Lead sponsor: Mount Sinai Hospital, Canada; Other
Eligibility: 18 Years and older · Female only
Enrollment: 1,230 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2025
U.S. locations: 2
States / cities: Evanston, Illinois • Chapel Hill, North Carolina

Conditions: Prostate Cancer
Interventions: Mindfulness Program; Behavioral
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: Evanston, Illinois

Search by objective public record fields.

Reversal of Neuromuscular Blockade in Thoracic Surgical Patients

Postpartum Ultrasound Evaluation to Assess Risk of Hemorrhage

How Variations in Pharmacogenomic Profiles Affect Pain and Narcotic Needs Following Total Knee Arthroplasty (TKA)

Prenatal Sonographic Prediction of Placental Histology and Function

The Use of the Propeller Health Platform to Improve Inhaled Corticosteroid (ICS) Use Among Adults With Uncontrolled Persistent Asthma

IVIG in the Treatment of Autoimmune Small Fiber Neuropathy With TS-HDS, FGFR-3, or Plexin D1 Antibodies

3-arm Study of Abiraterone Acetate Alone, Abiraterone Acetate Plus Degarelix, a GnRH Antagonist, and Degarelix Alone for Patients With Prostate Cancer With a Rising PSA or a Rising PSA and Nodal Disease Following Definitive Radical Prostatectomy

Tissue Adhesive vs. Sterile Strips After Cesarean Delivery

Phenotyping of Idiopathic Pelvic Pain With Real-time Uterine Imaging and Relugolix-Combination Therapy Treatment

Protocol for Admission Toxigenic C. Difficile Surveillance

Lymphedema Treatment in Head and Neck Cancer Patients

Dialogue Around Respiratory Illness Treatment

ICU CONNECT: Study Comparing EMG in Healthy Volunteers and ICU Patients.

Paricalcitol Versus Calcitriol for Efficacy and Safety in Stage 3/4 Chronic Kidney Disease (CKD) With Secondary Hyperparathyroidism (SHPT)

How Does the Clinical Tool 'What's Going Around' Affect Clinical Practice

Fasting Mimicking Diet (FMD) in Conjunction With Chemotherapy in Advanced Ovarian Cancer

Effect of Tizanidine on Postoperative Urinary Retention After Sacrospinous Suspension

Examining the Role of Improved NSAID Management in Treating Dysmenorrhea and Bladder Pain

Efficacy and Safety of Oral Rifaximin in Patients With Active Microscopic Colitis

Validation of PROMIS Banks With COPD Exacerbations

Effects of TNF Blockade on Human BPH/LUTS

Effects on Postoperative Pain of Liposomal Bupivacaine in Interscalene Blocks for Total Shoulder Arthroplasty Patients

Scaling Up Maternal Mental Healthcare by Increasing Access to Treatment (SUMMIT)

Mindfulness Online for Symptom Alleviation and Improvement in Cancer of the Prostate